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Yeast screening system reveals 
the inhibitory mechanism of 
cancer cell proliferation by benzyl 
isothiocyanate through down-
regulation of Mis12
Naomi Abe-Kanoh1,2,3, Narumi Kunisue1, Takumi Myojin1, Ayako Chino4, 
shintaro Munemasa1, Yoshiyuki Murata  1, Ayano satoh5, Hisao Moriya  4 & 
Yoshimasa Nakamura  1
Benzyl isothiocyanate (BItC) is a naturally-occurring isothiocyanate derived from cruciferous 
vegetables. BITC has been reported to inhibit the proliferation of various cancer cells, which is believed 
to be important for the inhibition of tumorigenesis. However, the detailed mechanisms of action remain 
unclear. In this study, we employed a budding yeast Saccharomyces cerevisiae as a model organism 
for screening. twelve genes including MTW1 were identified as the overexpression suppressors for the 
antiproliferative effect of BITC using the genome-wide multi-copy plasmid collection for S. cerevisiae. 
Overexpression of the kinetochore protein Mtw1 counteracts the antiproliferative effect of BITC in 
yeast. The inhibitory effect of BITC on the proliferation of human colon cancer HCT-116 cells was 
consistently suppressed by the overexpression of Mis12, a human orthologue of Mtw1, and enhanced 
by the knockdown of Mis12. We also found that BITC increased the phosphorylated and ubiquitinated 
Mis12 level with consequent reduction of Mis12, suggesting that BITC degrades Mis12 through an 
ubiquitin-proteasome system. Furthermore, cell cycle analysis showed that the change in the Mis12 
level affected the cell cycle distribution and the sensitivity to the BITC-induced apoptosis. These results 
provide evidence that BItC suppresses cell proliferation through the post-transcriptional regulation of 
the kinetochore protein Mis12.
Naturally-occurring isothiocyanates (ITCs), such as benzyl ITC (BITC), phenethyl ITC (PEITC) and sulfora-
phane (SFN) derived from cruciferous vegetables, have been demonstrated to block the tumor formation initiated 
by chemicals in experimental animals, and the dietary consumption of ITCs has been shown to strongly correlate 
with the reduced risk of various cancers in humans1–4. The antiproliferative effect of ITCs through the induction 
of cell cycle arrest and apoptosis is believed to be one of the important determinants for the inhibition of tum-
origenesis. For example, BITC induces cell cycle arrest at the G2/M phase by a p38 mitogen-activated protein 
kinase (MAPK)-dependent pathway in human leukemia Jurkat cells5 and by an extracellular signaling-regulated 
kinase-dependent pathway in human pancreatic cancer Capan-2 cells6. Also BITC induces apoptosis by the mito-
chondrial death pathway in rat liver epithelial RL34 cells7 and by a c-Jun-N-terminal kinase-dependent path-
way in Jurkat cells. However, the detailed molecular mechanism involved in the antiproliferative effect of ITCs 
remains to be clarified.
The identification of molecular targets of ITCs conferring their antiproliferative ability contributes to the 
understanding of the molecular basis of ITCs8. As electrophiles, ITCs can covalently bind to cellular nucleophilic 
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amino acids, such as Cys and Lys. Mi et al. found a correlation between the covalent binding to the cellular pro-
teins and antiproliferative effect of ITCs9. Consistent with this report, the direct binding of ITCs to several pro-
teins, such as tubulin10, macrophage migration inhibitory factor11 and DNA topoisomerase II alpha12, are likely to 
be associated with the antiproliferative ability of ITCs. Proteomics analysis by 2-dimensional gel electrophoresis 
has recently been used to screen the binding targets of ITCs and identified 30 proteins as the binding targets of 
ITCs in vitro13. However, the binding targets of ITCs identified by proteomics include several proteins abundantly 
existing in the cells, such as actin, tubulin and vimentin14. The low binding specificity of ITCs makes it difficult to 
find the molecular targets specifically contributing to the antiproliferative effect of ITCs. Therefore, the paradigm 
shift of the screening system is needed in terms of the requirement of the targets for the ITC-induced phenotype.
Budding yeast Saccharomyces cerevisiae is a eukaryotic model organism which has been frequently used in 
scientific studies due to its easy and cheap cultivation, short generation time and the ease of the application of 
molecular techniques for its genetic manipulation15,16, and widely employed for the identification of drug targets 
and mechanism of action studies17. The yeast screening system would be especially useful for the identification 
of target molecules contributing to the antiproliferation by ITCs, because ITCs exert an antiproliferative effect in 
yeast as well as in human cancer cells18, and antiproliferative agents often target the components of cell division 
and DNA repair machineries which are highly conserved between humans and yeast. One of the approaches to 
identify small-molecule targets is a multi-copy suppression screening for genes that provide resistance to a drug 
on overexpression. This screening is based on the principle that cells overexpressing a small-molecule target 
should tolerate the higher levels of the drug19. In addition, the yeast genome has been entirely sequenced and 
includes about 6000 open reading frames (ORFs)20,21. Based on the genome, we previously developed pRS423ks, 
a genome-wide multi-copy plasmid collection of S. cerevisiae22. Briefly, each gene with its native regulatory ele-
ments (promoter and terminator) is cloned to a 2-micron-based plasmid vector. Plasmid vectors derived from 
a 2-micron circle, which is a naturally-observed selfish DNA in S. cerevisiae, have copy numbers of 10 to 40 
per cell23. Although the promoter swapping using the strong promoter, such as GAL1, causes an absolute gene 
overexpression, pRS423ks causes a relative gene overexpression from the native level. We then tried to identify 
the molecular targets for the antiproliferative effect of BITC by the introduction of the plasmid collection to the 
wild-type yeast strain and the following examination of individual transformants for resistance to BITC.
To investigate the mechanisms of antiproliferation by BITC in human cancer cells, we conducted a 
genome-wide overexpression screening in yeast and applied the results obtained from the yeast to human cancer 
cells. By the screening, 12 genes, including MTW1 encoding an essential component of the MIND kinetochore 
complex, were identified as overexpression suppressors of antiproliferation by BITC in yeast. We found that the 
down-regulation of Mis12, a human orthologue of Mtw1, plays an important role in the antiproliferation by BITC 
in human colon cancer HCT-116 cells. Our data indicated that the proteasome-dependent decrease in Mis12 
induces G2/M delay and enhances the BITC-induced apoptosis, which contributes to the suppression of cancer 
cell proliferation by BITC.
Results
BItC dose-dependently suppresses yeast cell growth. To determine the concentration of BITC for 
the yeast screening, we examined the effect of BITC on the yeast cell growth by calculating the maximum growth 
rate in the yeast BY4741 strain. As shown in Fig. 1, the maximum growth rate decreased with the increasing con-
centrations of BITC, which suggests that BITC dose-dependently suppresses the proliferation of yeast. Since the 
treatment of BITC at a too low or too high concentration makes it difficult to detect the recovery of the maximum 
growth rate by overexpressing genes, we decided to use 100 μM BITC for the screening.
Figure 1. BITC inhibits cell growth in yeast. Yeast BY4741 cells were incubated in the YPD medium with 
different concentrations of BITC in a 96 well-plate. The time-lapse change in absorbance at 595 nm was 
measured using a microplate reader. Based on these data, the maximum growth rate was calculated. The values 
represent means ± SEM of three separate experiments (*P < 0.05 compared with control; Student’s t-test).
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Overexpression of 12 genes contributes to BITC resistance in yeast. The scheme of yeast screen-
ing by BITC is shown in Fig. 2. First is a BITC treatment step: transformants of BY4741 cells with 8 groups of 
pRS423ks, a genome-wide multi-copy plasmid collection of yeast22 (about 750 ORFs/group), were treated with 
100 μM BITC at 30 °C for 3 days in YPD liquid medium. Second is a colony formation step; a cell suspension 
from each well was spotted and cultivated on synthetic complete without the His (SC-His) agar plate at 30 °C for 
3 days. Third is a major gene searching step; inserted DNA in the plasmid was amplified by colony PCR, digested 
by restriction enzyme and separated by gel electrophoresis to find the same patterns of the inserted DNA. The 
plasmid DNA of a sample with the same frequently seen (more than 2 times) band patterns was selected and 
isolated. Fourth is a DNA sequencing step; 15 gene candidates were identified by DNA sequencing using the 
isolated plasmids and primers. To validate the screening, pRS423ks plasmids with the sequences of the 15 iden-
tified genes were cloned by Escherichia coli and introduced to yeast again, then the transformants were subjected 
to a spot assay. As shown in Fig. 3, overexpression of the 12 genes (ATP10, BAP2, COX23, MTW1, RCM1, RRT5, 
RTS3, STP1, UBP7, YDR262W, YGR017W and YML100W-A), but not overexpression of 3 genes (SQT1, TAT1 
Figure 2. Scheme of screening for overexpression suppressors of antiproliferation by BITC in yeast. 
Transformants of BY4741 cells with pRS423ks were treated with 100 μM BITC for 3 days in YPD medium. 
Yeasts from each well were cultured on an SC-His agar plate. Formed colonies were subjected to colony PCR 
to amplify the inserted DNA into the plasmid. The PCR products were digested with restriction enzymes and 
separated by gel electrophoresis. Only the plasmid DNA of the samples with a major band fragmentation 
















































Figure 3. Validation of screening by spot assay. BY4741 cells were transformed with pRS423ks with ORF of 
each of the 15 genes identified by screening and empty vector (control). The transformants were treated with the 
indicated concentrations of BITC for 30 min in YPD medium. The cell suspensions were spotted on a YPD agar 
plate. The number of colonies was counted to determine the cell viability. The values represent means ± SEM of 
three separate experiments (*P < 0.05 compared between overexpression (OE) group of each gene and control 
at the same concentrations of BITC; Student’s t-test).
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and YOL019W), significantly weakened the antiproliferative effect of BITC compared to the control group (empty 
vector), suggesting that the overexpression of these 12 genes contributes to the BITC resistance in yeast (Table 1).
Change in Mis12 level affects the sensitivity to BITC in human cancer cells. We focused on 
MTW1 among the 12 identified genes because the function and structure of yeast Mtw1 are highly conserved 
in the human orthologue of Mtw1, Mis12. Mis12, an essential component of the Mis12 kinetochore complex in 
humans, is required for the appropriate chromosome segregation during mitosis24. In human colon cancer HCT-
116 cells, we examined the effects of the overexpression and knockdown of Mis12 on the antiproliferation by 
BITC. The Mis12 protein level in HCT-116 cells stably overexpressing Mis12 (Mis12 OE cells) was about 1.7 times 
higher than that in the vector control (Fig. 4A). The Mis12 overexpression itself didn’t affect the cell proliferation 
(Fig. 4B). As shown in Fig. 4C, the antiproliferative effect of BITC in Mis12 OE cells was significantly attenuated 
compared to the vector control, which is consistent with the result from the yeast in Fig. 3. The transfection of 
HCT-116 cells with 30 nM Mis12-specific siRNA depleted the Mis12 protein level by 16% compared to control 
(Fig. 4D). Mis12 knockdown alone weakly, but significantly, suppressed the cell proliferation (Fig. 4E). As shown 
in Fig. 4F, BITC itself dose-dependently suppressed cell proliferation in the control siRNA-treated group, whereas 
the Mis12 knockdown enhanced the antiproliferative effect of BITC. These results suggested that the expression 
level of Mis12 in human as well as Mtw1 in yeast affects the antiproliferative effect of BITC.
BITC induces proteasome-dependent decrease of Mis12 in HCT-116 cells. We examined the effect 
of BITC on the protein expression of Mtw1 in yeast and Mis12 in HCT-116 cells. For detection of the Mtw1 pro-
tein expression, we used the yeast strain whose MTW1 sequence on the genome is replaced with the MTW1-TAP 
sequence by homogeneous recombination. Western blot analysis using the anti-TAP-tag and anti-Mis12 antibod-
ies showed that BITC significantly decreased the Mtw1-TAP level in yeast (Fig. 5A) and the Mis12 level not only 
in HCT-116 cells, but also in immortalized non-tumorigenic human epidermal (HaCaT) cells (Fig. 5B,C). In addi-
tion, the anti-cancer agent paclitaxel decreased the Mis12 level and cell viability in HCT-116 cells (Fig. 5J,K). The 
decrease of Mis12 was observed 1 h after the BITC treatment and continued for 24 h after treatment (Fig. 5D). A 
previous study indicated that Mis12 appears to localize on DNA throughout the cell cycle24. Immunofluorescence 
data showed that BITC didn’t affect the subcellular localization of Mis12 on DNA but significantly decreased the 
Mis12 fluorescent signal (Fig. 5E). Although the results in mitotic phase were shown as the representative pictures 
in Fig. 5E, we also confirmed that the fluorescent foci of Mis12 were observed on DNA in interphase (data not 
shown). Furthermore, we observed the misaligned chromosome in the BITC-treated HCT-116 cells (Fig. 5F). 
This finding is consistent with a previous report showing that the siRNA-mediated down-regulation of Mis12 
induces misalignment of the chromosomes in HeLa cells25.
Next, to check whether or not the decrease of the Mis12 protein level by BITC is regulated by the transcrip-
tional level, we investigated the effect of BITC on the mRNA expression of MIS12. As shown in Fig. 5G, BITC 
showed no significant effect on the MIS12 mRNA expression in HCT-116 cells. We next examined the effect 
of proteasome inhibitor, MG132, on the BITC-decreased Mis12 protein level. The co-incubation with MG132 
impaired the BITC-decreased expression of the Mis12 protein (Fig. 5H). Since some phosphorylated proteins 
could be recognized as the substrates of the E3 ubiquitin ligase and degraded through an ubiquitin-proteasome 
pathway, we performed an immunoprecipitation assay to examine the post-transcriptional modification of 
Mis12. As expected, BITC drastically increased the phosphorylated Mis12 and tended to induce the ubiquiti-
nation of Mis12 (Fig. 5I). These results suggested that BITC degrades the Mis12 protein, possibly through the 
ubiquitin-proteasome pathway without affecting its gene expression or subcellular localization.
Down-regulation of Mis12 increases G2/M cell population and enhances BITC-induced apop-
tosis in HCT-116 cells. The BITC-induced chromosome misalignment may cause delay in mitosis. 
Consistently, BITC delays the cell cycle progression at G2/M phase and induces G2/M phase-specific apop-
totic cell death in human leukemia Jurkat cells. Thus, we hypothesized that the decrease in Mis12 enhances the 
BITC-induced apoptosis by increasing the G2/M cell population in HCT-116 cells. To test this hypothesis, we 
Gene Brief description*
ATP10 Assembly factor for mitochondrial F1F0 ATP synthase
BAP2 Branched-chain amino acid permease
COX23 Copper chaperone for cytochrome c oxidase
MTW1 Essential component of the MIND kinetochore complex
RCM1 rRNA m5C methyltransferase
RRT5 Unknown
RTS3 Putative component of protein phosphatase 2A complex





Table 1. Overexpression suppresser genes of antiproliferation by BITC in yeast. *Saccharomyces genome 
database: http://www.yeastgenome.org.
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examined the effect of the overexpression or knockdown of Mis12 on cell cycle regulation by BITC. In the vector 
group, BITC increased the G2/M and Sub-G1 cell population (Fig. 6A,B), the latter of which is characterized as the 
apoptotic cells26. On the other hand, the Mis12 overexpression cancelled the BITC-increased G2/M cell popula-
tion and partly, but significantly, attenuated the BITC-increased Sub-G1 cell population. Compared with the con-
trol siRNA-transfected group, Mis12 knockdown alone increased the G2/M cell population, but not the sub-G1 
cell population (Fig. 6C,D). Moreover, the increase in the sub-G1 cell population by BITC was enhanced by the 
Mis12 knockdown. These data suggested that BITC increases the G2/M cell population, possibly by reducing the 
Mis12 level and thus sensitizing the cells to the BITC-induced apoptosis.
Discussion
In the present study, we originally developed the yeast screening system as a reliable and convenient tool to 
identify overexpression suppressors for the antiproliferative effect of BITC. As shown in Table 1, the 12 identi-
fied genes in yeast includes ATP synthase (ATP10), amino acid transport system (BAP2 and STP1), cytochrome 
c oxidase Cu chaperon (COX23), kinetochore complex (MTW1), deubiquitinating enzymes (DUBs) (UBP7), 
ribosomal RNA (rRNA) methyltransferase (RCM1) and protein phosphatase type 2A (PP2A) complex (RTS3). 
According to the Saccharomyces genome database, Bap2, Cox23, Mtw1, Ubp7 and Rcm1 are recognized as the 
human homologs of SLC7A5-10, CHCHD7, Mis12, USP2, 8, 21 and NSUN5, respectively. Because the structure 
is highly similar between homologs and the overexpression of each gene increases the resistance against BITC, 
they might play a pivotal role in the BITC-induced antiproliferation in both the yeast and human cells. Among the 
identified 12 factors, ATP synthase, cytochrome c oxidase Cu chaperon and DUB have already been identified as 
the direct binding targets for PEITC, an aromatic ITC analogue of BITC, by an in vitro proteomics study using the 
human cancer cell lysate13. The existence of such common hits between our screening and previous proteomics 
analysis further confirmed the usefulness of our yeast screening system and also implies that the down-regulation 
or dysfunction of these proteins by the direct binding of BITC contributes to its antiproliferative effect. For exam-
ple, the collapse of the mitochondrial electron transport system through the direct binding of BITC to ATP syn-
thase or cytochrome c oxidase Cu chaperon might induce apoptosis. This idea is supported by the finding that the 
mitochondrial death pathway is involved in BITC-induced apoptosis7.
Our screening system identified other types of factors contributing to the BITC resistance such as the com-
ponents of the amino acid transport system (Bap2 and Stp1). Bap2 is the branched-amino acid transporter that 
Figure 4. Change in Mis12 protein level affects the sensitivity of cells to the antiproliferative effect of BITC. The 
Mis12 protein level was determined by a Western blot analysis. Actin was used as a loading control. The viability 
was determined by a trypan blue dye exclusion assay. (A) Mis12 protein level in HCT-116 cells stably expressing 
HA-Mis12 (Mis12 OE cells) was determined. pQCXIP (vector) was used as the control. (B) Mis12 OE and 
control cells (2 × 106) were cultured for 24 h and the viability was determined. (C) Mis12 OE and control cells 
(2 × 106) were treated with BITC for 24 h and the cell viability was determined. (D&E) HCT-116 cells were 
transfected with the control siRNA or Mis12-specific siRNA. The Mis12 protein level (D) and viability (E) were 
then determined. (F) HCT-116 cells were transfected with the control siRNA or Mis12-specific siRNA. After 
the treatment with BITC for 24 h, the cell viability was determined. The values represent means ± SEM of three 
separate experiments (*P < 0.05 compared between the indicated groups; Student’s t-test).
6Scientific RepoRts |          (2019) 9:8866  | https://doi.org/10.1038/s41598-019-45248-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 5. BITC decreases Mis12 protein expression in a proteasome-dependent manner. The Mtw1/Mis12 
protein level was determined by a Western blot analysis. Total protein staining or actin was used as the loading 
control. (A) BY4741 cells expressing the Mtw1-TAP were treated with BITC for 24 h and Mtw1-TAP protein 
level was determined. (B) HCT-116 cells were treated with BITC for 24 h and the Mis12 protein level was 
determined. (C) HaCaT cells were treated with BITC for 24 h and the Mis12 protein level was determined. 
(D) HCT-116 cells were treated with 20 μM BITC for the indicated hours and the Mis12 protein level was 
determined. (E) HCT-116 cells stably expressing HA-Mis12 were treated with 20 μM BITC for 1 h. The signals 
of HA-Mis12 (green) and DNA (blue) were detected by immunofluorescence. The signal intensity of HA-Mis12 
at each kinetochore was measured relative to an adjacent background signal. Bar, 10 µm. Fluorescence intensity 
was quantified using Image J software. (F) HCT-116 cells were treated with 20 μM BITC for 1 h. The signals of 
the microtubules (green) and DNA (blue) were detected by immunofluorescence. Bar, 10 µm. (G) HCT-116 cells 
were treated with BITC for 24 h and the Mis12 mRNA level was determined by RT-PCR. (H) HCT-116 cells 
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mediates the uptake of leucine, isoleucine and valine to the cells27. Stp1 regulates the transcription of amino acid 
transporters including Bap228,29. The increased expression of the L-type amino acid transporters (LATs), the major 
transporters that regulate uptake of leucine to cells, is the hallmark of many kinds of human cancers30. There 
is now strong evidence that leucine enhances the mammalian target of the rapamycin complex 1 (mTORC1) 
signaling which modulates protein synthesis to regulate cell growth, proliferation and cellular differentiation31. 
Furthermore, we have recently reported that an mTOR inhibitor, NVP-BEZ235, potentiated the BITC-induced 
apoptosis induction in human colorectal cancer cells32. Thus, the inhibition of the mTORC1 pathway through the 
down-regulation of the LATs might contribute to the antiproliferative effect of BITC in human cells. Similarly, the 
attenuation of the antiproliferative effect of BITC by overexpressing the rRNA methyltransferase might be attrib-
uted to the facilitation of protein synthesis because methylation of the rRNA regulates ribosome maturation33.
In this study, we identified a kinetochore protein Mtw1, a well-conserved orthologue of human Mis12, as 
one of the overexpression suppressors for the antiproliferative effect of BITC using the yeast screening system. 
Our data showed that the antiproliferative effect of BITC was not only inhibited by the Mis12 overexpression in 
HCT-116 cells, but also enhanced by the Mis12 knockdown (Fig. 4C,F). The Mis12 knockdown alone induced 
G2/M delay but not apoptosis in HCT-116 cells and synergistically enhanced the antiproliferative effect of BITC 
accompanied with acceleration of the BITC-induced apoptosis (Figs 4F and 6). These observations suggested 
that the accumulation of the G2/M cell population is involved in the increased sensitivity to the BITC-induced 
apoptosis. This idea is supported by the report showing that BITC induces the G2/M phase-specific apoptosis in 
human leukemia Jurkat cells5. PP2A, a factor identified by our screening, is a family of serine/threonine protein 
phosphatases that regulates many cellular processes including cell cycle regulation, apoptosis, protein synthesis, 
cell morphology and development34,35. Down-regulation of the PP2A-B55 complex accelerates entry into mitosis 
and inhibits exit from mitosis. The inactivation of PP2A induces apoptosis in many cancer cells36. Based on these 
findings, the overexpression of the PP2A component might weaken the antiproliferative effect of BITC by inhibit-
ing the BITC-induced M delay and apoptosis. However, PP2A regulates cell growth both positively and negatively 
due to the formation of a multitude of different PP2A holoenzyme complexes37. Thus, the individual role in each 
of the PP2A complexes in the antiproliferative effect of BITC needs to be clarified.
We also found that BITC enhanced Mis12 phosphorylation and tended to induce Mis12 ubiquitination (Fig. 5I) 
and decreased Mis12 in a proteasome-dependent manner (Fig. 5H), suggesting that the post-transcriptional reg-
ulation of Mis12 plays a key role in the antiproliferative effect of BITC. Although previous research indicated 
that Mis12 is phosphorylated at Ser190 or Thr192, and Ser213 in Schizosaccharomyces pombe possibly by Gsk3 
kinase24, the mechanism stabilizing kinetochore attachment of Mis12 is still unknown. The phosphorylation sites 
of human Mis12 and their effect on the stability should be elucidated in the future researches. We identified 
UBP7 encoding DUB, a large group of proteases that cleave ubiquitin from proteins and other molecules includ-
ing ubiquitin-specific proteases (USPs) and ubiquitin C-terminal hydrolases (UCHs). Since dysregulation of the 
ubiquitin-proteasome system has been suggested to play an important role in the pathogenesis of many human 
diseases including cancer38, DUBs are promising targets for cancer treatment through the interference with the 
ubiquitin regulation machinery39. For example, the knockdown of USP7 actually exerts an antiproliferative effect 
through induction of cell cycle arrest in HCT-116 cells40. Since proteomics analysis also identified DUB as a direct 
target of the ITC compound13, the DUB dysfunction through the direct binding of BITC might contribute to 
the Mis12 degradation by the ubiquitin-proteasome system. In fact, a very recent study revealed that BITC and 
PEITC inhibit the activity of USP9x and UCH37, possibly through the direct modification to the Cys residue in 
the catalytic domain of the DUBs41, supporting our hypothesis. However, there is another possibility that the 
phosphorylation and ubiquitination of Mis12 is followed by the BITC-induced cell cycle delay. Therefore, the 
further studies on the upstream signaling of Mis12 phosphorylation are required. Since the ITCs-bound proteins 
are also degraded in a proteasome-dependent manner, the direct modification of the target proteins by BITC 
is another possible mechanism of the Mis12 down-regulation. A recent study revealed that the subunits of the 
multi-protein complex including the MIND kinetochore complex composed of Mtw1, Dsn1, Nsl1 and Nnf1 were 
subjected to tuning toward the fine proportion at the protein level by the ubiquitin-proteasome system in yeast42. 
We preliminary found that BITC drastically decreased the protein level of the human Dsnl in HCT-116 cells (data 
not shown). These results suggest that Mis12 affects the stability of the subunits of the human Mis12 complex 
other than Mis12 and becomes the promising target of the anti-cancer agent.
The human Mis12 kinetochore complex, a heterotetramer composed of Mis12, Dsn1, Nsl1and Nnf1, connects 
the centromere region on the chromosome to the mitotic spindle microtubule and is essential for the kinetochore 
assembly and proper chromosome segregation24,25. Mis12 depletion induces the high frequency of misaligned 
metaphase chromosomes and lagging chromosomes in anaphase, followed by the frequent appearance of micro-
nuclei in the interphase. These mitotic and interphase abnormalities should cause chromosome missegregation 
and aneuploidy, an aberrant number of chromosomes24,43. Consistent with these reports, we observed chromo-
some misalignment induced by BITC (Fig. 5F). This result indicated that BITC induces aneuploidy through the 
down-regulation of Mis12. Targeting the components involved in the mitotic regulation is a major strategy of 
were treated with 10 μM MG132 and/or 20 μM BITC for 24 h, and the Mis12 protein level was determined. (I) 
HCT-116 cells stably expressing HA-Mis12 were treated with 10 μM MG132 and/or 20 μM BITC for 30 min. 
The whole cell lysates were immunoprecipitated with the HA antibody and visualized by a Western blot analysis 
with ubiquitin, phosphoserine/threonine/tyrosine or HA-tag antibody. (J) HCT-116 cells were treated with 
100 nM paclitaxel for 24 h and subjected to Western blot analysis to detect Mis12 signal. Actin was used as a 
loading control. (K) HCT-116 cells were treated with 100 nM paclitaxel for 24 h and subjected to MTT assay to 
measure cell viability. The values represent means ± SEM of three separate experiments (*P < 0.05 compared 
with control; Student’s t-test).
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Figure 6. Change in Mis12 protein level affects the sensitivity of cells to BITC-induced apoptosis. (A,B) Cells 
in the Mis12 OE and vector group were treated with BITC for 24 h and subjected to a cell cycle distribution 
analysis using Tali™ image-based cytometer. The representative histogram is shown in (A). The G2/M and Sub-
G1 cell populations were statistically analyzed in (B). (C,D) HCT-116 cells were transfected with the control 
siRNA or Mis12-specific siRNA. After the treatment with BITC for 24 h, the cell cycle distribution was analyzed 
as (A). The representative histogram is shown in (C). The G2/M and Sub-G1 cell populations were statistically 
analyzed in (D). The values represent means ± SEM of three separate experiments. Data were analyzed by a one-
way analysis of variance (ANOVA) followed by multiple comparisons among the means (Tukey’s HSD) using 
XLSTAT software (Addinsoft, Paris, France). Different letters above the bars indicate significant differences 
among the treatments for each compound (P < 0.05).
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cancer therapy, whereas the induction of delay in mitosis causes not only the cell death but also aneuploidy44. 
Recent study revealed that paclitaxel, a first-line anti-cancer agent inhibiting the depolymerization of spindle 
microtubules, induces aneuploidy to suppress proliferation in a clinically relevant concentration range in breast 
cancer45. Paclitaxel as well as BITC decreased the protein level of Mis12 at the concentration where it suppresses 
cell proliferation in HCT-116 cells (Fig. 5J,K). These findings suggest that the induction of aneuploidy is an effec-
tive strategy for cancer therapy, while aneuploidy has ever been recognized to be a hallmark of cancer devel-
opment. Some researchers argue that aneuploidy is simply a by-product of tumorigenesis46, while others argue 
that aneuploidy is the driving force of tumorigenesis47. This confusion may be due to various factors including 
the heterogenic nature of cancers and the individual genetic alteration in humans48. Since BITC decreased the 
protein level of Mis12 in non-tumorigenic HaCaT cells as well as in tumorigenic HCT-116 cells (Fig. 5B,C), it 
is very important to examine whether or not the down-regulation of Mis12 by BITC causes carcinogenesis in 
various cell types including normal cells. Although the agents targeting the components of kinetochore complex 
including Ndc80 and Nuf2 have been shown to have anti-cancer effects49–51, this is the first report, to the best of 
our knowledge, to show the mechanism to suppress cancer cell proliferation through the degradation of Mis12. 
This finding is expected to contribute to the development of the new anti-cancer drug targeting Mis12 as well as 
other kinetochore complex members.
Here, we proposed the regulating role of Mis12 in the BITC-induced suppression of proliferation in HCT-116 
cells due to G2/M delay and apoptosis in Fig. 7. However, the other study implies that the cell cycle inhibition 
by ITCs is caused through the disruption of spindle structure by the ITC binding to tubulin10. Furthermore, the 
decrease of Mis12 level by paclitaxel, which is known to cause the spindle disruption up to the dose, suggests 
the probability that the spindle disruption leads to the downregulation of Mis12. Thus, it is also possible that the 
disruption of spindle structure by BITC is followed by cell cycle inhibition and Mis12 degradation. Even though 
the Mis12 overexpression canceled the cell cycle inhibition by BITC (Fig. 6B), the excess Mis12 may impair the 
disruption of spindle structure to interfere with the BITC binding to tubulin. Future studies should be directed 
to clarify the detailed mechanism of the down-regulation of Mis12 level by BITC. Our yeast screening system 
requires a lower cost, shorter time and simpler operations compared to the human cell screening system. We 
also revealed the commonality between the molecules identified by our screening and possible binding targets 
of BITC previously reported13, suggesting the high utility of our screening system. Although we did not provide 
evidence that BITC targets Mis12 directly or indirectly, future efforts will be concerned with chemical detection of 
the BITC-modified Mis12 by mass spectrometry or by immunoprecipitation using the antibody recognizing the 
Lys adduct of BITC52. Furthermore, because inhibition of the DUB activity by BITC is the most plausible indirect 
pathway, it should be clarified whether the DUB modification by BITC contributes to the proteasome-dependent 
Mis12 degradation.
Materials and Methods
Chemicals and antibodies. BITC was purchased from LKT Laboratories, Inc. (St Paul, MN). Antibodies 
against Mis12 (#98368, 1:200), ubiquitin (#sc-8017, 1:200) and actin (#sc-8432, 1:200), and horseradish peroxi-
dase-linked anti-rabbit and anti-mouse IgGs, Mis12-specific siRNA, control siRNA, siRNA transfection medium, 
siRNA transfection reagent and Protein A/G PLUS-Agarose Immunoprecipitation reagents were purchased from 
Figure 7. Proposed model of antiproliferation by BITC. BITC has been shown to induce G2/M arrest and 
apoptosis in various cancer cells. BITC possibly decreases Mis12 protein level by inducing the phosphorylation, 
ubiquitination and proteasomal degradation of it. The reduced-Mis12 level causes G2/M delay, but not apoptosis 
and enhances the apoptosis induction by BITC. Thus, the down-regulation of Mis12 contributes to the 
antiproliferative effect of BITC by inducing G2/M delay and sensitizing cells to the BITC-induced apoptosis.
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Santa Cruz Biotechnology (Santa Cruz, CA). Antibody against phosphoserine/threonine/tyrosine (#ab15556, 
1:1000) was purchased from abcam (Cambridge, United Kingdom). Peroxidase anti-peroxidase soluble com-
plex (PAP) antibody (#P3039, 1:1000), propidium iodide (PI) and RNase A were purchased from Sigma-Aldrich 
(St. Louis, MO). Antibody against HA-Tag (#3724, 1:1000) was purchased from Cell Signaling Technology, Inc. 
(Beverly, MA). Alexa Fluor-linked anti-rabbit and anti-mouse IgGs, McCoy’s 5A, penicillin/streptomycin, trypan 
blue stain, FastDigest EcoRI, FastDigest HindIII, Pierce® BCA Protein Assay Kit and Trizol® reagent were pur-
chased from Thermo Fisher Scientific (Waltham, MA). Fatal bovine serum (FBS) was purchased from Nichirei 
Corporation (Tokyo, Japan). Immobilon-P membrane was purchased from Merck Millipore (Billerica, MA). Taq 
polymerase and PrimeScriptTM RT Master Mix (Perfect Real Time) were purchased from Takara Bio Inc. (Shiga, 
Japan). Paclitaxel was purchased from Wako Pure Chemical Industries (Osaka, Japan). All other chemicals were 
purchased from Nakalai Tesque Inc. (Kyoto, Japan).
Yeast strain, growth conditions and yeast transformation. S. cerevisiae strain BY4741 (MATa 
his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)53 was used for yeast screening system. S. cerevisiae MTW1-TAP strain 
obtained from Funakoshi Co., Ltd. (Tokyo, Japan) was used for Western blot analysis. Yeast cultivation and trans-
formation were performed as previously described54. SC-His was used for the selection of yeast transformed with 
plasmid.
Generation of gene overexpression library of yeast. To generate the gene overexpression library of 
S. cerevisiae, BY4741 strain was transformed with pRS423ks and plated on minimal media lacking His. Because 
BY4741 strain harbors inactivated his3 genes, it cannot grow on His-lacking medium. However, the genomic 
DNA of the yeast strain from which the library was constructed has the functional HIS3 genes. Thus, the presence 
of a plasmid in the library that contains HIS3 genes in BY4741 strain will restore growth to a transformant on 
medium lacking His.
Measurement of maximum growth rate. Yeast growth was measured by monitoring OD595 every 
30 min at 30 °C using a microplate reader (Model 680XR, Bio-Rad Laboratories, Hercules, CA). Maximum 
growth rate was calculated as described previously54.
Screening for overexpression suppressors of antiproliferation by BITC in yeast. The entire 
scheme of yeast screening system is described as follows. A genome-wide multi-copy plasmid library of S. cere-
visiae cloned into pRS423ks22 was divided to 8 groups for convenience and introduced into BY4741 cells. The 8 
groups of transformants were cultivated in SC-His medium until mid-log phase, seeded to 96 well-plate and cul-
tured in YPD liquid medium with 100 μM BITC for 3 days at 30 °C. The cell suspension in each well was plated onto 
SC-His agar plate and incubated for 3 days at 30 °C. Relatively big colonies were picked up and subjected to colony 
PCR using primers 5′-AAGATCAACACTGCCAAAGCG-3′ and 5′-AGCCATATCAATACGGCGAACATC-3′ to 
amplify DNA sequence of gene inserted in plasmid. PCR product was digested with EcoRI and HindIII for 1 h at 
37 °C and separated by 1% agarose gel electrophoresis. Plasmid DNA from colony with the same band pattern fre-
quently seen here (more than 2 times) was isolated by Yeast DNA miniprep as previously described54. Escherichia 
coli XL1-Blue Electroporation Competent Cell (Agilent Technologies, Santa Clara, CA) was transformed with the 
isolated yeast DNA by electroporation and plated on ampicillin-containing LB plate. Plasmid DNA was isolated 
by E. coli DNA miniprep as previously described54. DNA sequence of insert in the plasmid was determined by 
the service of Macrogen japan (Tokyo, Japan) using primers 5′-CGGCCGCTCTAGAACTAGTGGATCC-3′ and 
5′-ATTGGGTACCGGGCCCCCCCTCGAG-3′. To re-evaluate the suppressor activity of the identified candidate 
gene, suppressor plasmid was transfected to yeast again and performed spot assay.
spot assay. Yeast cells were cultured in YPD liquid medium with BITC (100, 500 and 1000 µM) or 0.1% 
DMSO for 30 min. The cell suspension was diluted 1, 100 and 500 times with YPD liquid medium and the diluent 
of cell suspension (10 μl) was spotted onto YPD agar plate. After 2 days cultivation, the number of colonies was 
counted.
Human cell line and cell culture. Human colon cancer cell line HCT-116 was obtained from the American 
Type Culture collection (ATCC) (Manassas, VA). HCT-116 cells were maintained in McCoy’s 5A medium supple-
mented with 10% heat-inactivated FBS and 1% penicillin/streptomycin. Immortalized non-tumorigenic human 
epidermal cell line HaCaT was kindly provided by Shiseido Research Center (Yokohama, Japan). HaCaT cells 
were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% heat-inactivated FBS and 0.5% 
penicillin/streptomycin. Cells were grown at 37 °C in an atmosphere of 95% and 5% CO2.
Western blot analysis. The experiments for yeast cells55 and for human cells56 were performed as previously 
described. Briefly, whole cell lysates were subjected to SDS-PAGE and transferred to PVDF membrane and the 
chemiluminescent picture was taken after immunoblotting using antibodies. Densitometric analysis of the bands 
was carried out using the Image J Software Program.
RNA interference. Cells were cultured in 6-well plates (2 × 105 cells per well) in normal growth medium 
without antibiotic and transfected with siRNA. Predesigned siRNA targeting Mis12 or nonspecific control siRNA 
were transfected to the cells according to the manufacturer’s instructions using siRNA transfection medium and 
siRNA transfection reagent. After the incubation for appropriate time, cells were assayed using the appropriate 
protocol.
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Trypan blue dye exclusion assay. Trypan blue dye exclusion assay was carried out for quantitative analysis 
of cell viability. Cell suspensions were mixed with 0.4% Trypan blue stain. Viable cells (cells that excluded blue 
dye) were counted using a hemocytometer (Bürker-Türk) under a light microscope.
Mtt assay. MTT assay was carried out for quantitative analysis of cell viability as previously described56. 
Briefly, cells were treated with MTT solution and the absorbance was measured at 570 nm after 2 h-incubation 
at 37 °C.
Rt-pCR. Cells were washed with ice-cold phosphate buffered saline (PBS) (−). Total cellular RNA was iso-
lated using Trizol reagent according to the manufacturer’s recommendations. RNA was quantified by meas-
uring absorbance at 260 nm. Total RNA (0.5 μg) was reverse transcribed using PrimeScriptTM RT Master 
Mix (Perfect Real Time). PCR amplification was then performed with Taq polymerase and specific prim-
ers. Primers used in PCR amplification are as follows: MIS12, 5′-CAGGCCGTTGAACAGGTTAT-3′ and 
5′-TCAGCTGCAAAAACAGTTGC-3′ (160 bp); and β-ACTIN, 5′-GTCACCCACACTGTGCCCATCTA-3′ and 
5′-GCAATGCCAGGGTACATGGTGGT-3′ (455 bp). The PCR products were then subjected to agarose gel elec-
trophoresis (3%), stained with ethidium bromide and photographed. Densitometric analysis of the bands was 
carried out using the Image J Software Program.
plasmid and stable cell line. Plasmid to express Mis12 was kindly provided by Drs. Mitsuhiro Yanagida 
and Takeshi Hayashi (Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan). Mis12 
cDNA fused with HA-tag sequence at N-terminal was produced by PCR and subcloned into pQCXIP (Clontech, 
Mountain View, CA). HCT-116 cells stably expressing HA-Mis12 were established as previously described57.
Immunoprecipitation assay. Cells were washed with ice-cold PBS (−), lysed in RIPA buffer (50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% Sodium deoxycholate and 1 mM EDTA) containing pro-
tease inhibitor cocktail and phosphatase inhibitor cocktail, and left on ice for 15 min. After sonication, lysates 
were centrifuged and the supernatant was used as whole cell lysates. Whole cell lysates (800 μg protein) were 
incubated with HA antibody for 24 h at 4 °C. Then, 20 μl Protein A/G PLUS-Agarose Immunoprecipitation rea-
gents were added and the mixture was incubated for 2 h at 4 °C. Beads were washed with lysis buffer three times. 
Immunoprecipitated proteins were subjected to Western blot analysis.
Cell cycle analysis. After treatment, the culture supernatant was collected, and the cells were detached by 
trypsin treatment. The detached cells were suspended in the collected culture supernatant. After the centrifuga-
tion at 1,500 rpm for 5 min at 4 °C, cells were stained with PI solution (20 μg/ml PI, 0.1% Triton X-100, 0.2 μg/
ml RNase A in PBS (−)) for 30 min under dark condition at room temperature. Stained cells were analyzed by a 
Tali™ Image Based Cytometer (Thermo Fisher Scientific, Waltham, MA).
Immunofluorescence microscopy. Cells on coverslips were fixed with 4% paraformaldehyde (PFA) in 
PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 5 min at room temperature. The cells were 
blocked with 4% bovine serum albumin (BSA) in PBS for 15 min, and then incubated for 15 min with primary 
antibodies diluted in 4% BSA in PBS. The cells were washed three times with PBS, and incubated for 15 min with 
secondary antibodies conjugated to Alexa fluorophors. After washing the cells, the coverslips were mounted on 
microscope slides and imaged using a IX71 fluorescent microscope equipped with a 60 × objectives (Olympus, 
Tokyo, Japan). Image data were processed and quantified using Image J software. The signal intensity of HA-Mis12 
was determined by measuring the integrated fluorescence intensity within a 3 × 3 pixel square positioned over 
a single HA-Mis12 signal and subtracting the background intensity of a 3 × 3 pixel square positioned in a corre-
sponding background. A minimum of 3 cells and 10 kinetochore foci per cell were measured for each condition 
each experiment (each replicated a minimum of three times).
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